Volver a Agenda
Session 3: Hot Topics – A Regulators’ Perspective
Session Chair(s)
Doris Irene Stenver, MD, MPA
Independent Pharmacovigilance Adviser, Unique Advice, Denmark
Speaker(s)
PRAC updates
Independent Pharmacovigilance Adviser, Unique Advice, Denmark
Feedback on PRAC´s First Public Hearing and Highlights on Signal Management
Former PRAC Chair, Medicines Evaluation Board (MEB), Netherlands
The RMP in the life cycle of the product – originator/generic/biosimilar
Scientific Senior Specialist (Risk Management), European Medicines Agency, Netherlands
The RMP in the life cycle of the product – originator/generic/biosimilar
Scientific Specialist (Risk Management), European Medicines Agency, Netherlands
¿Tiene una cuenta?